Euro Heart Survey 2009 Snapshot: Regional variations in presentation and management of patients with AMI in 47 countries

Etienne Puymirat, Alex Battler, John Birkhead, Hector Bueno, Peter Clemmensen, Yves Cottin, Keith Aa Fox, Bulent Gorenek, Christian Hamm, Kurt Huber, Maddalena Lettino, Bertil Lindahl, Christian Müller, Alexander Parkhomenko, Susanna Price, Tom Quinn, Francois Schiele, Maarten Simoons, Gabriel Tatu-Chitoiu, Marco TubaroChristiaan Vrints, Doron Zahger, Uwe Zeymer, Nicolas Danchin, Nicolas Danchin, Alex Battler, Hector Bueno, Keith Fox, Christian Hamm, Bertil Lindahl, Francois Schiele, Maarten Simoons, Michal Tendera, Marco Tubaro, Anselm Gitt

Research output: Contribution to journalArticlepeer-review


Aims: Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey. Methods: Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House. Results: Overall, 4236 patients (mean age 66±}13 years; 31% women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50% having primary percutaneous coronary intervention and 21% fibrinolysis. Aspirin and thienopyridines were used in >90%. Unfractionated and low-molecularweight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzymeinhibitors were used in >80% of the patients. In-hospital mortality was 6.2%. Regional differences were observed, both in terms of population characteristics, management, and outcomes. Conclusions: In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.

Original languageEnglish
Pages (from-to)359-370
Number of pages12
JournalEuropean Heart Journal: Acute Cardiovascular Care
Issue number4
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Euro Heart Survey 2009 Snapshot: Regional variations in presentation and management of patients with AMI in 47 countries'. Together they form a unique fingerprint.

Cite this